Stay updated on Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 in the page footer; no substantive changes to the study content or details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedAdded a note that Publications are auto-filled from PubMed and may not reflect the study, and updated the page revision to v3.3.1; the prior PubMed note and v3.2.0 revision were removed.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved an administrative notice about government funding and NIH operating status; the study details, eligibility, and outcomes sections remain unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedThe update appears non-substantive, reflecting a refreshed last-updated timestamp and minor UI adjustments without changing core study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedCore content updated to include an official operating-status notice and new version (v3.2.0); the previous version tag (v3.1.0) was removed.SummaryDifference3%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.